本页面由Tiger Trade Technology Pte. Ltd.提供服务

Can-Fite Biopharma Ltd

1.95
+0.05002.63%
盘前:1.90-0.0500-2.56%08:06 EDT
成交量:2.44万
成交额:4.75万
市值:591.14万
市盈率:0.00
高:2.02
开:1.91
低:1.91
收:1.90
52周最高:12.30
52周最低:1.90
股本:303.15万
流通股本:214.25万
量比:0.61
换手率:1.14%
股息:- -
股息率:- -
每股收益(TTM):-977.1003
每股收益(LYR):-1,791.0249
净资产收益率:-211.37%
总资产收益率:-77.12%
市净率:1.22
市盈率(LYR):0.00

数据加载中...

2020/01/09

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/01/09

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/01/08

超过5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/01/07

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/01/06

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/01/03

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/12/26

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/12/20

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/12/12

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/12/09

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/11/29

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/11/19

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/11/12

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/11/06

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/11/04

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/10/31

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/10/24

超过5%披露

[Amend] General statement of acquisition of beneficial ownership
2019/10/18

[修订]招股说明书

[Amend] Registration statement for certain foreign private issuers
2019/10/18

SEC问询函

[Cover]Correspondence
2019/10/17

超过5%披露

[Amend] General statement of acquisition of beneficial ownership